The CEO of General Catalyst says that longevity care should be reimbursable
Briefly

The CEO of General Catalyst says that longevity care should be reimbursable
"Hemant Taneja, CEO and managing director of the global venture capitalist firm, told the "TPBN" podcast on Friday that he thinks investments in personal health and longevity should be reimbursable and covered by insurance. "There's a ton more that needs to be done so that the system moves toward incentives that keep us healthy and out of the hospital, versus a high-performance but really expensive, unaffordable care if we go into the hospital," Taneja told show host John Coogan and Jordi Hays."
""There's no model that'll show what's the ROI on this where insurance companies pay for it," Taneja added of longevity care. "The insurers don't know if they make an investment in longevity, they're going to be able to capture the value on the other side." General Catalyst has made many moves in the healthcare space. In 2017, the VC cofounded healthcare startup Commure and has raised over $1 billion since then."
Health insurance currently covers a narrow set of preventative measures, primarily screenings for diseases such as cancer and HIV, while supplement medications and therapies targeting aging cells are generally excluded. Investments in personal health and longevity lack reimbursable pathways because insurers do not have clear models to calculate and capture return on investment. A major venture capital firm has expanded in healthcare, cofounding Commure in 2017, raising over $1 billion, and acquiring the Summa Health system for $485 million to convert a nonprofit hospital into a for-profit entity. Longevity research and interventions have become prominent interests among Silicon Valley elites.
Read at Business Insider
Unable to calculate read time
[
|
]